Testing the stability of a new vaccine formulation
Task V27: Stability Testing of CpG
['FUNDING_OTHER'] · ADVANCED BIOSCIENCE LABORATORIES, INC. · NIH-10475966
This study is working on creating and testing new vaccines to help protect people from serious infections, especially those that could be used in harmful ways, so that patients can have better options for staying healthy in the future.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ADVANCED BIOSCIENCE LABORATORIES, INC. (nih funded) |
| Locations | 1 site (KENSINGTON, UNITED STATES) |
| Trial ID | NIH-10475966 on ClinicalTrials.gov |
What this research studies
This research focuses on the development and testing of vaccines and biologics aimed at combating infectious diseases, particularly those that could be used in bioterrorism. It involves planning, optimizing, and manufacturing vaccine products in compliance with regulatory standards for clinical trials. Patients may benefit from the development of new vaccines that could protect against emerging infectious diseases. The research includes thorough assessments and audits to ensure safety and efficacy before vaccines are submitted for FDA approval.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for infectious diseases, particularly those related to bioterrorism or emerging pathogens.
Not a fit: Patients with non-infectious diseases or those not at risk for emerging infectious diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that protect against serious infectious diseases.
How similar studies have performed: Previous research has shown success in developing vaccines through similar methodologies, indicating a promising approach.
Where this research is happening
KENSINGTON, UNITED STATES
- ADVANCED BIOSCIENCE LABORATORIES, INC. — KENSINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NEUBERT, ANDREAS — ADVANCED BIOSCIENCE LABORATORIES, INC.
- Study coordinator: NEUBERT, ANDREAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Infectious Disease Pathway, Infectious Diseases, Infectious Disorder, Communicable Diseases